February 2024
US$ 29.75
semaglutide and lupus Do SGLT2 GLP-1 therapies have a role in Lupus? Ozempic and autoimmune disease: Safety
Description
As the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) expands, so too does our knowledge of just what all these medications can do
The primary goal is not weight loss, it is receptor adaptation
Bazzett TJ, Becker JB
weight loss trajectory still accelerating at this point in Phase 2 data Personalized Treatment at Rewind Anti-Aging Choosing the right weight loss medication is not a one-size-fits-all decision
Not absent, which would be concerning, but manageable
